2.15 Was the patient given anticoagulant Yes Available if 2.1.7 = and 2.5 = PIH. ‘Yes’ reversal therapy? No Refers to specific treatment to reverse the effects of anticoagulant treatment, including PCC (Prothrombin Complex Concentrate), DOAC antidote, FFP (Fresh Frozen Plasma), Protamine and/or Vitamin K. 2.15.1 If yes, What reversal agent PCC 2.15.1. Available if 2.15 = Select all that apply. ‘Yes’. was given? DOAC antidote FFP PCC = Prothrombin Complex Concentrate Protamine DOAC antidote = Direct Oral Anticoagulant antidote. Includes Vitamin K Idarucizumab, Andexanet alfa. FFP = Fresh Frozen Plasma Protamine Vitamin K 2.15.2 Data and time reversal agent was dd/mm/yyyy hh:mm Available if 2.15 = ‘Yes’. given. Time of of infusion If more than one reversal agent given, enter time of first reversal agent. Must be after time of arrival/onset of stroke for inpatients. 3.3a Date and time contact was first dd/mm/yyyy hh:mm Cannot be later than 72h after clock start. made with a stroke specialist No contact made consultant physician about this case Enter the date and time of first contact with a stroke specialist consultant (whether in person or otherwise) regarding this patient following a clinical assessment. The purpose of the following a clinical assessment clinical assessment is to make a decision about how the patient will be managed, and therefore this assessment needs to be undertaken by a competent professional trained in undertaking assessments of neurological patients. The assessment would normally include examination of the patient, taking a detailed history, and would take the results of the imaging into consideration. First contact with the consultant can be made in person, by telephone or via telemedicine (must include the option to view the patient via video if required). In scenarios where the paramedic had received specific training to undertake assessments of neurological patients, this first contact could be before the patient arrives at hospital.
2.15 Was the patient given anticoagulant reversal therapy? Yes No Available if 2.1.7 = ‘Yes’ and 2.5 = PIH. Refers to specific treatment to reverse the effects of anticoagulant treatment, including PCC (Prothrombin Complex Concentrate), DOAC antidote, FFP (Fresh Frozen Plasma), Protamine and/or Vitamin K. 2.15.1 If yes, 2.15.1. What reversal agent was given? PCC DOAC antidote FFP Protamine Vitamin K Available if 2.15 = ‘Yes’. Select all that apply. PCC = Prothrombin Complex Concentrate DOAC antidote = Direct Oral Anticoagulant antidote. Includes Idarucizumab, Andexanet alfa. FFP = Fresh Frozen Plasma Protamine Vitamin K 2.15.2 Data and time reversal agent was given. dd/mm/yyyy hh:mm Available if 2.15 = ‘Yes’. Time of of infusion If more than one reversal agent given, enter time of first reversal agent. Must be after time of arrival/onset of stroke for inpatients. 3.3a Date and time contact was first made with a stroke specialist consultant physician about this case (whether in person or otherwise) following a clinical assessment dd/mm/yyyy hh:mm No contact made Cannot be later than 72h after clock start. Enter the date and time of first contact with a stroke specialist consultant regarding this patient following a clinical assessment. The purpose of the clinical assessment is to make a decision about how the patient will be managed, and therefore this assessment needs to be undertaken by a competent professional trained in undertaking assessments of neurological patients. The assessment would normally include examination of the patient, taking a detailed history, and would take the results of the imaging into consideration. First contact with the consultant can be made in person, by telephone or via telemedicine (must include the option to view the patient via video if required). In scenarios where the paramedic had received specific training to undertake assessments of neurological patients, this first contact could be before the patient arrives at hospital.
SSNAP_Dataset_Changes_Helpnotes_2017.docx